Zobrazeno 1 - 10
of 39
pro vyhledávání: '"Raffaella Losito"'
Autor:
Daniele Roberto Giacobbe, Laura Labate, Chiara Russo Artimagnella, Cristina Marelli, Alessio Signori, Vincenzo Di Pilato, Chiara Aldieri, Alessandra Bandera, Federica Briano, Bruno Cacopardo, Alessandra Calabresi, Federico Capra Marzani, Anna Carretta, Annamaria Cattelan, Luca Ceccarelli, Giovanni Cenderello, Silvia Corcione, Andrea Cortegiani, Rosario Cultrera, Francesco Giuseppe De Rosa, Valerio Del Bono, Filippo Del Puente, Chiara Fanelli, Fiorenza Fava, Daniela Francisci, Nicholas Geremia, Lucia Graziani, Andrea Lombardi, Angela Raffaella Losito, Ivana Maida, Andrea Marino, Maria Mazzitelli, Marco Merli, Roberta Monardo, Alessandra Mularoni, Chiara Oltolini, Carlo Pallotto, Emanuele Pontali, Francesca Raffaelli, Matteo Rinaldi, Marco Ripa, Teresa Antonia Santantonio, Francesco Saverio Serino, Michele Spinicci, Carlo Torti, Enrico Maria Trecarichi, Mario Tumbarello, Malgorzata Mikulska, Mauro Giacomini, Anna Marchese, Antonio Vena, Matteo Bassetti, CEFI-SITA investigators
Publikováno v:
Infectious Diseases and Therapy, Vol 13, Iss 9, Pp 1929-1948 (2024)
Abstract Introduction Cefiderocol is a siderophore cephalosporin showing activity against various carbapenem-resistant Gram-negative bacteria (CR-GNB). No data currently exist about real-world use of cefiderocol in terms of types of therapy (e.g., em
Externí odkaz:
https://doaj.org/article/4d37e965db0a44d0bffbac2110da4e02
Autor:
Daniele Roberto Giacobbe, Carolina Saffioti, Angela Raffaella Losito, Matteo Rinaldi, Caterina Aurilio, Cesare Bolla, Silvia Boni, Guglielmo Borgia, Novella Carannante, Giovanni Cassola, Giancarlo Ceccarelli, Silvia Corcione, Daniela Dalla Gasperina, Francesco Giuseppe De Rosa, Chiara Dentone, Stefano Di Bella, Nicoletta Di Lauria, Marcello Feasi, Marco Fiore, Sara Fossati, Erica Franceschini, Andrea Gori, Guido Granata, Sara Grignolo, Paolo Antonio Grossi, Giuliana Guadagnino, Filippo Lagi, Alberto Enrico Maraolo, Valeria Marinò, Maria Mazzitelli, Alessandra Mularoni, Alessandra Oliva, Maria Caterina Pace, Andrea Parisini, Francesca Patti, Nicola Petrosillo, Vincenzo Pota, Francesca Raffaelli, Marianna Rossi, Antonella Santoro, Carlo Tascini, Carlo Torti, Enrico Maria Trecarichi, Mario Venditti, Pierluigi Viale, Alessio Signori, Matteo Bassetti, Valerio Del Bono, Maddalena Giannella, Malgorzata Mikulska, Mario Tumbarello, Claudio Viscoli
Publikováno v:
Journal of Global Antimicrobial Resistance, Vol 20, Iss , Pp 43-49 (2020)
Objectives: The aim of this study was to assess colistin use in a country endemic for multidrug-resistant Gram-negative bacteria (MDR-GNB). Methods: Colistin prescription patterns were evaluated in 22 Italian centres. Factors associated with use of c
Externí odkaz:
https://doaj.org/article/99430e89aa2c4eae9aaaae3790823514
Autor:
Augusto Di Castelnuovo, Simona Costanzo, Andrea Antinori, Nausicaa Berselli, Lorenzo Blandi, Marialaura Bonaccio, Raffaele Bruno, Roberto Cauda, Alessandro Gialluisi, Giovanni Guaraldi, Lorenzo Menicanti, Marco Mennuni, Ilaria My, Agostino Parruti, Giuseppe Patti, Stefano Perlini, Francesca Santilli, Carlo Signorelli, Giulio G. Stefanini, Alessandra Vergori, Walter Ageno, Luca Aiello, Piergiuseppe Agostoni, Samir Al Moghazi, Rosa Arboretti, Filippo Aucella, Greta Barbieri, Martina Barchitta, Alessandro Bartoloni, Carolina Bologna, Paolo Bonfanti, Lucia Caiano, Laura Carrozzi, Antonio Cascio, Giacomo Castiglione, Mauro Chiarito, Arturo Ciccullo, Antonella Cingolani, Francesco Cipollone, Claudia Colomba, Crizia Colombo, Francesco Crosta, Giovanni Dalena, Chiara Dal Pra, Gian Battista Danzi, Damiano D'Ardes, Katleen de Gaetano Donati, Francesco Di Gennaro, Giuseppe Di Tano, Gianpiero D'Offizi, Tommaso Filippini, Francesco Maria Fusco, Carlo Gaudiosi, Ivan Gentile, Giancarlo Gini, Elvira Grandone, Gabriella Guarnieri, Gennaro L. F. Lamanna, Giovanni Larizza, Armando Leone, Veronica Lio, Angela Raffaella Losito, Gloria Maccagni, Stefano Maitan, Sandro Mancarella, Rosa Manuele, Massimo Mapelli, Riccardo Maragna, Lorenzo Marra, Giulio Maresca, Claudia Marotta, Franco Mastroianni, Maria Mazzitelli, Alessandro Mengozzi, Francesco Menichetti, Jovana Milic, Filippo Minutolo, Beatrice Molena, R. Mussinelli, Cristina Mussini, Maria Musso, Anna Odone, Marco Olivieri, Emanuela Pasi, Annalisa Perroni, Francesco Petri, Biagio Pinchera, Carlo A. Pivato, Venerino Poletti, Claudia Ravaglia, Marco Rossato, Marianna Rossi, Anna Sabena, Francesco Salinaro, Vincenzo Sangiovanni, Carlo Sanrocco, Laura Scorzolini, Raffaella Sgariglia, Paola Giustina Simeone, Michele Spinicci, Enrico Maria Trecarichi, Giovanni Veronesi, Roberto Vettor, Andrea Vianello, Marco Vinceti, Elena Visconti, Laura Vocciante, Raffaele De Caterina, Licia Iacoviello, The COVID-19 RISK and Treatments (CORIST) Collaboration
Publikováno v:
Frontiers in Medicine, Vol 8 (2021)
Background: Protease inhibitors have been considered as possible therapeutic agents for COVID-19 patients.Objectives: To describe the association between lopinavir/ritonavir (LPV/r) or darunavir/cobicistat (DRV/c) use and in-hospital mortality in COV
Externí odkaz:
https://doaj.org/article/f4c84c197fec47feaef5530f66820b4b
Publikováno v:
Antibiotics, Vol 11, Iss 5, p 579 (2022)
P. aeruginosa is still one of the most threatening pathogens responsible for serious hospital-acquired infections. It is intrinsically resistant to many antimicrobial agents and additional acquired resistance further complicates the management of suc
Externí odkaz:
https://doaj.org/article/4c4a029d55994643b07686d7352f871b
Autor:
Paola Del Giacomo, Francesca Raffaelli, Angela Raffaella Losito, Barbara Fiori, Mario Tumbarello
Publikováno v:
Antibiotics, Vol 11, Iss 2, p 193 (2022)
Background: Pseudomonas aeruginosa represents, among the nosocomial pathogens, one of the most serious threats, both for the severity of its clinical manifestations and its ability to develop complex profiles of resistance; Methods: we retrospectivel
Externí odkaz:
https://doaj.org/article/8d1ea679fb374bf1b4c1a0257db024fe
Autor:
Daniele Roberto Giacobbe, Michele Mirabella, Matteo Rinaldi, Angela Raffaella Losito, Francesca Raffaelli, Filippo Del Puente, Carolina Saffioti, Malgorzata Mikulska, Maddalena Giannella, Pierluigi Viale, Mario Tumbarello, Matteo Bassetti, on behalf of SITA GIOVANI (Young Investigators Group of the Società Italiana Terapia Antinfettiva) and the COLI-CROSS Study Group
Publikováno v:
Antibiotics, Vol 10, Iss 12, p 1554 (2021)
Colistin is a last-resort agent for the treatment of infections due to Gram-negative bacteria with difficult-to-treat resistance. The primary objective of this post hoc analysis of a cross-sectional study conducted in 22 Italian hospitals was to asse
Externí odkaz:
https://doaj.org/article/067b7a313aff458d84e905667e468872
Autor:
Daniele Roberto Giacobbe, Malgorzata Mikulska, Mario Tumbarello, Elisa Furfaro, Marzia Spadaro, Angela Raffaella Losito, Alessio Mesini, Gennaro De Pascale, Anna Marchese, Marco Bruzzone, Paolo Pelosi, Michele Mussap, Alexandre Molin, Massimo Antonelli, Brunella Posteraro, Maurizio Sanguinetti, Claudio Viscoli, Valerio Del Bono, on behalf of ISGRI-SITA (Italian Study Group on Resistant Infections of the Società Italiana Terapia Antinfettiva)
Publikováno v:
Critical Care, Vol 21, Iss 1, Pp 1-9 (2017)
Abstract Background This study aimed to assess the combined performance of serum (1,3)-β-d-glucan (BDG) and procalcitonin (PCT) for the differential diagnosis between candidaemia and bacteraemia in three intensive care units (ICUs) in two large teac
Externí odkaz:
https://doaj.org/article/51893c452618479897d0fad43c5e1c6a
Autor:
Paola, Del Giacomo, Francesca, Raffaelli, Angela Raffaella, Losito, Barbara, Fiori, Mario, Tumbarello
Publikováno v:
Antibiotics (Basel, Switzerland). 11(2)
Autor:
Mario Tumbarello, Francesca Raffaelli, Antonio Cascio, Marco Falcone, Liana Signorini, Cristina Mussini, Francesco Giuseppe De Rosa, Angela Raffaella Losito, Gennaro De Pascale, Renato Pascale, Daniele Roberto Giacobbe, Alessandra Oliva, Alberto Farese, Paola Morelli, Giusy Tiseo, Marianna Meschiari, Paola Del Giacomo, Francesca Montagnani, Massimiliano Fabbiani, Joel Vargas, Teresa Spanu, Matteo Bassetti, Mario Venditti, Pierluigi Viale
Publikováno v:
Università degli Studi di Siena-IRIS
Objectives To explore the real-life performance of meropenem/vaborbactam for treating serious KPC-producing Klebsiella pneumoniae infections, including those resistant to ceftazidime/avibactam. Methods A retrospective observational cohort study was c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dcfe10a4962d1c24a4a7214ae9bec892
https://hdl.handle.net/11585/894961
https://hdl.handle.net/11585/894961
Autor:
Mario, Tumbarello, Francesca, Raffaelli, Antonio, Cascio, Marco, Falcone, Liana, Signorini, Cristina, Mussini, Francesco Giuseppe, De Rosa, Angela Raffaella, Losito, Gennaro, De Pascale, Renato, Pascale, Daniele Roberto, Giacobbe, Alessandra, Oliva, Alberto, Farese, Paola, Morelli, Giusy, Tiseo, Marianna, Meschiari, Paola, Del Giacomo, Francesca, Montagnani, Massimiliano, Fabbiani, Joel, Vargas, Teresa, Spanu, Matteo, Bassetti, Mario, Venditti, Pierluigi, Viale
Publikováno v:
JAC-antimicrobial resistance. 4(1)
To explore the real-life performance of meropenem/vaborbactam for treating serious KPC-producingA retrospective observational cohort study was conducted in 12 Italian hospitals. Enrolled patients hadThe 37 infections (all hospital-acquired) were main